HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
$13.99−0.41 (-2.85%)
Close on Nov 18, 2026Market cap $2.44BP/E 5.4Yield –
HUTCHMED (China) net income
Net income is the profit left for shareholders after every expense, interest and tax.
HUTCHMED (China)'s net income for the twelve months ending Dec 31, 2019 was -$106.02M. For fiscal 2025 it was $456.91M, up 1111.0% from the year before. Over ten years it grew 49.9% a year on average. The highest annual figure on record is $456.91M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $456.91M | +1111.0% |
| FY2024 | Dec 31, 2024 | $37.73M | -62.6% |
| FY2023 | Dec 31, 2023 | $100.78M | – |
| FY2022 | Dec 31, 2022 | -$360.84M | – |
| FY2021 | Dec 31, 2021 | -$194.65M | – |
| FY2020 | Dec 31, 2020 | -$125.73M | – |
| FY2019 | Dec 31, 2019 | -$106.02M | – |
| FY2018 | Dec 31, 2018 | -$74.81M | – |
| FY2017 | Dec 31, 2017 | -$26.74M | -328.6% |
| FY2016 | Dec 31, 2016 | $11.70M | +46.4% |
| FY2015 | Dec 31, 2015 | $7.99M | – |
| FY2014 | Dec 31, 2014 | -$7.31M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | -$29.56M | – |
| Q3 FY2019 | Sep 30, 2019 | -$31.09M | – |
| Q2 FY2019 | Jun 30, 2019 | -$25.48M | – |
| Q1 FY2019 | Mar 31, 2019 | -$19.89M | – |
| Q4 FY2018 | Dec 31, 2018 | -$16.54M | – |
| Q3 FY2018 | Sep 30, 2018 | -$25.58M | – |
| Q2 FY2018 | Jun 30, 2018 | -$20.96M | – |
| Q1 FY2018 | Mar 31, 2018 | -$11.73M | – |
See a number that looks wrong?